US drug approvals
111 approvals with a product on the US market
- Lenalidomide ANDA218872 · approved 14 Nov 2025
- Clomiphene Citrate ANDA219406 · approved 3 Oct 2025
- Camcevi Etm NDA219745 · approved 25 Aug 2025
- Dehydrated Alcohol ANDA217845 · approved 23 Jun 2025
- Progesterone ANDA217707 · approved 21 Nov 2023
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.